For this Interview with the Innovators series, several interviews were conducted with executives and scientists from Genmab, an international biotech company with 24 years of experience in developing cutting-edge antibodies and antibody technology. The participants discussed a diverse range of topics, including the company’s ability to develop products at scale to serve the entire range of stakeholders in the healthcare ecosystem, the importance of Genmab’s data- and science-driven approach to research, and the innovative corporate culture at the heart of the company’s evolution.
A Passion for Scientific Innovation and a Company Culture That Values Customers Drive the Teams at Genmab to Discover Cutting-Edge Solutions for People with Cancer
Genmab Unleashes the Power of Strategic Alliances to Advance the Science of Therapeutic Antibodies for People with Cancer
Genmab Is Developing a World-Class Antibody Portfolio with the Hope to Bring the Right Cancer Therapy for the Right Patient
Introducing Genmab-Rooted in Science and Inspired by Patients to Transform the Future of Cancer Treatment
Results 1 - 6 of 6